Jeff Atwater, Chief Finance Officer of Florida, Cornelia Quennet-Thielen, German State Secretary of the Federal Ministry of Education and Research, Prof. Peter Gruss, Max Planck Society President, and Dr. David Fitzpatrick, the Max Planck Florida Institute Scientific Director and CEO, opened the brand new Max Planck Florida Institute for Neuroscience (MPFI) at an official ceremony in Jupiter, Florida. It is the first institute of the Max Planck Society, which is based in Germany, to be located in the United States.
Recent PostsSaturday, January 14, 2017
The University of South Florida College of Engineering and the USF Health Morsani College of Medicine have established the Department of Medical Engineering, a unique transdisciplinary concept that will combine the related aspects of engineering and medicine while providing access to real-world health care environments for education and research. ..Read More ⇒Thursday, January 12, 2017
Florida-based Flight Level Engineering has become the first company to join the Customized Business Acceleration Program at the John Mica Engineering and Aerospace Innovation Complex (MicaPlex) at Embry-Riddle Research Park in Daytona Beach. ..Read More ⇒Thursday, January 12, 2017
According to a 2015 report by the NIH’s National Institute on Aging, in the last five years of life, total health care spending for people with dementia was more than a quarter of a million dollars per person, 57 percent more than the costs associated with death from other diseases, including cancer and heart disease. ..Read More ⇒Thursday, January 12, 2017
Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Moffitt Cancer Center is working on a new vaccine that would help early-stage breast cancer patients who have HER2 positive disease. ..Read More ⇒Wednesday, January 11, 2017
Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants. In a new study published as the cover story in Science Translational Medicine, Moffitt Cancer Center researchers show that a novel treatment can effectively inhibit the development of GVHD in mice and maintain the infection- and tumor-fighting capabilities of the immune system. ..Read More ⇒
Tagsconsumers sustainability Florida Trend engineering Sanford-Burnham Florida Power & Light biotechnology Moffitt Cancer Center IHMC awards photonics Nanotheraputics Nova Southeastern Univ. Max Planck BioFlorida accounting research policy Torrey Pines Institute biochemistry conference / event aging agriculture AxoGen robotics animals Florida Institute of Technology University of West Florida astronomy Florida Atlantic University accolades HIV/AIDS University of Miami Mayo Clinic University of Central Florida bioscience GrowFL magnets health care FAMU FL Institute for Commercialization of Public Research research ICFO gender environment Scripps Research Institute commercialization University of North Florida physics technology health Florida Hospital biomedical accreditation ecology Univeristy of South Florida AGTC education policy economy cancer business Jackson Lab Embry-Riddle green technology Florida Gulf Coast Univ. Enterprise Florida VGTI Draper innovation Florida State University University of Florida medical grants society/culture nanotechnology stem cell neuroscience Florida International Univ. marine sciences computer science materials science aerospace clean energy children partnerships Banyan Biomarkers energy